Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticlePROCEEDINGS OF THE 21st ANNUAL MEETING OF THE SOCIETY OF BIOTHERAPEUTIC APPROACHES

Radiosensitizing Effect of 5-Aminolevulinic Acid and Protoporphyrin IX on Carbon-ion Beam Irradiation

TOMOKO KANEKO, MASAHIDE TOMINAGA, RISA KOUZAKI, AYAKA HANYU, KAZUKI UESHIMA, HISATSUGU YAMADA, MASAKI SUGA, TOMOHIRO YAMASHITA, TOMOAKI OKIMOTO and YOSHIHIRO UTO
Anticancer Research July 2018, 38 (7) 4313-4317; DOI: https://doi.org/10.21873/anticanres.12730
TOMOKO KANEKO
1SAGA Heavy Ion Medical Accelerator in Tosu, Tosu, Japan
2Graduate School of Technology, Industrial and Social Sciences, Tokushima University, Tokushima, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MASAHIDE TOMINAGA
3Graduate School of Biomedical Sciences, Tokushima University, Tokushima, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: uto.yoshihiro@tokushima-u.ac.jp tominaga@tokushima-u.ac.jp
RISA KOUZAKI
2Graduate School of Technology, Industrial and Social Sciences, Tokushima University, Tokushima, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
AYAKA HANYU
2Graduate School of Technology, Industrial and Social Sciences, Tokushima University, Tokushima, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KAZUKI UESHIMA
2Graduate School of Technology, Industrial and Social Sciences, Tokushima University, Tokushima, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HISATSUGU YAMADA
2Graduate School of Technology, Industrial and Social Sciences, Tokushima University, Tokushima, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MASAKI SUGA
4Hyogo Ion Beam Medical Center, Tatsuno, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TOMOHIRO YAMASHITA
4Hyogo Ion Beam Medical Center, Tatsuno, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TOMOAKI OKIMOTO
4Hyogo Ion Beam Medical Center, Tatsuno, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YOSHIHIRO UTO
2Graduate School of Technology, Industrial and Social Sciences, Tokushima University, Tokushima, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: uto.yoshihiro@tokushima-u.ac.jp tominaga@tokushima-u.ac.jp
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Background/Aim: Carbon-ion beam is one of the most advanced radiations used for cancer treatment. However, there are tumors that are difficult to suppress with carbon-ion beam alone, thus necessitating development of drugs that can enhance its therapeutic effect. In this regard, the radiosensitizing effect of 5-aminolevulinic acid (ALA) and protoporphyrin IX (PpIX), that is a metabolic intermediate of ALA, on carbon-ion beam was investigated. Materials and Methods: Radiosensitizing activity, mitochondrial ROS and DNA double-strand break production of ALA and PpIX were evaluated by irradiation with 1.0 or 1.5-Gy carbon-ion beam to mouse mammary EMT6 tumor cells. Results: Combination of carbon-ion beam and ALA or PpIX showed a significant enhancement of its cytotoxic activity through a significant increase in ROS production in mitochondria. Furthermore, the combined activity of carbon-ion beam and ALA resulted in a significant increase in DNA double-strand breakage. Conclusion: ALA selectively accumulates in the mitochondria and PpIX synthesized from ALA reacts with carbon-ion beam to produce ROS that exert antitumor activity.

  • 5-Aminolevulinic acid
  • protoporphyrin IX
  • carbon-ion beam
  • reactive oxygen species
  • mitochondria

Carbon-ion beam is one of the most advanced radiations used for cancer treatment (1-3). They have higher LET (linear energy transfer) than conventional x-rays and induce cell death mainly by initiating DNA double-strand breaks (4, 5). In addition, since it has a Bragg peak where energy deposition reaches a maximum at a certain depth of the body, it can be irradiated with high accuracy in the cancer tissue, facilitating minimum side effects and shortened treatment period (6). Although it is said to be effective for the treatment of refractory cancer, there are tumors that are difficult to suppress with carbon-ion beam irradiation alone. Hence, the development of a drug that can further enhance its therapeutic effect is necessary. However, carbon-ion beams have strong DNA-damaging properties. Since the antitumor effect of reactive oxygen species (ROS) is relatively small, drugs that enhance the antitumor effect of carbon-ion beam have rarely been reported (7-9).

Therefore, this study, is focused on 5-aminolevulinic acid (ALA), a drug already in clinical use in photodynamic diagnosis/therapy (10-12). In cancer cells, protoporphyrin IX (PpIX), a metabolic intermediate of ALA, selectively accumulates in the mitochondria (13). It has been reported in recent years that irradiation of X-ray results in local enhancement of ROS production, thus improving its therapeutic effect (14-16). Therefore, we postulated that ALA can also increase ROS production in response to carbon-ion beam and may exhibit carbon-ion beam sensitizing action. In this study, the effect and the mechanism of ALA and PpIX on carbon-ion beam sensitization was examined, by monitoring their effects on ROS production in mitochondria and DNA double strand breakage.

Materials and Methods

Materials. 5-ALA hydrochloride was purchased from Cosmo Bio Co., Ltd. (Tokyo, Japan), PpIX from Tokyo Chemical Industry Co. Ltd. (Tokyo, Japan), MitoSOX Red and Mitotracker Green FM from Thermo Fisher Scientific Inc. (Waltham, MA, USA), Hoechst 33342 from PromoCell (Heidelberg, Germany).

Cell culture. Mouse mammary EMT6 tumor cells (supplied by Dr. Shin-ichiro Masunaga, Kyoto University, Kyoto, Japan) were maintained in Eagle's minimum essential medium (Sigma-Aldrich, Tokyo, Japan) supplemented with 10% fetal bovine serum (Biosera Ltd., Kansas City, MO, USA). Cells were cultured in a humidified atmosphere of 5% CO2 at 37°C.

Carbon-ion beam irradiation and evaluation of sensitizing activity of ALA and PpIX. EMT6 cells were seeded in flasks at 1×105 cells and cultured overnight. PpIX (1 μM) and ALA (1 mM) were added 24 and 5 hours, respectively, prior to carbon-ion beam irradiation. The cells were transported to the Hyogo Ion Beam Medical Center within 3 hours at 37°C. They were then irradiated with 1.0 and 1.5 Gy carbon-ion beam (320 MeV/nucleon, 83.3 keV/μm). Twenty-four hours after the irradiation, the cells were reseeded in a Petri dish and cultured for 8 days in 5% CO2 at 37°C. The medium was then removed and the cell surface was washed with 2 ml of 1× phosphate-buffered saline (PBS). Two milliliters of methanol were added and allowed to stand for about 10 min to fix the cells. Next, 2 ml of 5% Giemsa solution (Merck & Co., Inc., Kenilworth, NJ, USA) was added and colony staining was carried out for 1 h. After staining, the dish was washed with water and then dried. Thereafter, the number of colonies was counted to calculate the colony plating efficiency (PE) and the survival rate (SF).

Mitochondrial ROS detection. Mitochondrial ROS content was determined by measuring the fluorescence of MitoSOX Red. The EMT6 cells were seeded in a slide chamber (1×103 cells/well) and PpIX (1 μM) and ALA (1 mM) were added 24 and 5 h, respectively, prior to carbon-ion beam irradiation. The cells were transported to the Hyogo Ion Beam Medical Center within 3 hours at 37°C, and then irradiated with 1.0-Gy carbon-ion beam (320 MeV/nucleon, 83.3 keV/μm). Three hours after irradiation, the cells were washed with 1 × PBS. MitoSOX Red (5 μM) was added and incubated for 30 min at 37°C. After incubation, cells were washed twice with 1 × PBS and 500 μl of E-MEM was added. The fluorescence intensity of MitoSOX Red was measured at 640 nm excitation and 660 nm emission wavelengths using a fluorescence microscope BZ-X700 (KEYENCE Co. Ltd., Osaka, Japan).

DNA double-strand break detection. EMT6 cells were seeded in slide chamber (WATSON Co. Ltd., Tokyo, Japan) at 1×104 cells/well and cultured overnight. PpIX (1 μM) and ALA (1 mM) were added 24 and 5 h, respectively, prior to the carbon-ion beam irradiation. The cells were transported to the Hyogo Ion Beam Medical Center within 3 h at 37°C and irradiated with 1.0 and 1.5 Gy carbon-ion beam (320 MeV/nucleon, 83.3 keV/μm). Three hours after the carbon-ion beam irradiation, observation slides were prepared as follows: First, the cells were fixed for 15 min at 25°C using 500 μl of 4% paraformaldehyde/phosphate buffer solution. They were then washed twice with 1 × PBS and treated with 500 μl of 0.5% Triton solution at 4°C for 5 min. The cells were again washed twice with 1 × PBS and blocked with 500 μl of blocking solution at room temperature for 30 min. The fixed and blocked cells were then incubated in 300 μl of the primary antibody (Anti-phospho-Histone H2A.X (Ser139), clone JBW301, Merck KGaA, Darmstadt, Germany) solution at room temperature for 1 h. After incubation, washing was carried out three times with 300 μl of 0.5% Triton solution for 3 min each with shaking. This was followed by incubation for 30 min with 200 μl of the diluted secondary antibody (donkey anti mouse IgG affinity purified; fluorescein conjugated absorbed for dual labeling secondary antibody, Merck KGaA, Darmstadt, Germany) solution in a dark room. After incubation, washing was again carried out three times with 200 μl of 0.5% Triton solution for 3 min each with shaking. After washing, the slide was incubated for 15 minutes with 300 μl of DAPI (WAKO, Tokyo, Japan) solution, and then washed again three times with 1 × PBS. The slide was then removed from the treated chamber and dried. A cover glass was made using the Marinol (MUTO Pure Chemicals Co. Ltd., Tokyo, Japan), and the prepared slide was kept refrigerated in a dark room until observation. The fluorescence intensity of γ-H2AX focus was measured at 490 nm excitation and 525 nm emission wavelengths using a fluorescence microscope BZ-X700. Wells were divided into six sections, and the number of γ-H2AX focus of 50 cells per division was counted, and the average of six sections was calculated.

Localization of intracellular PpIX. EMT6 cells (5×103 cells) were inoculated on a glass dish and cultured overnight. Cultured cells were incubated with PpIX (1 μM) and ALA (1 mM) for 24 h and 5 h, respectively, washed once with 1 × PBS, and 100 nM of Mitotracker Green FM was added. Furthermore, 2 ng/ml of Hoechst 33342 was added. After incubation for 30 min, the cells were washed twice with 1 × PBS and observed under a serum-free E-MEM using a fluorescence microscope.

Statistical analysis. Data are expressed as the mean and standard deviations of at least three independent experiments. The statistical significance of the differences between the results was analyzed using Student's t-test. A p<0.05 was considered statistically significant.

Results

Radiosensitizing activity of ALA and PpIX on carbon-ion beam. According to previous studies, ALA and PpIX showed no cytotoxicity up to 1 mM and 1 μM as maximum intracellular PpIX concentrations were reached at 5 and 24 h, respectively (17, 18). We, therefore, chose the same condition in this experiment. Combined use of carbon-ion beam and ALA has an enhancement ratio (ER) of 1.16 (1 Gy) and 1.29 (1.5 Gy), showing a significant radiosensitizing effect as compared to the control (Figure 1). In addition, the combination of carbon-ion beam and PpIX showed a significant radiosensitizing effect compared to the control with ER=1.14 (1 Gy) and 1.18 (1.5 Gy) (Figure 1). There was no significant difference in the radiosensitizing activity to carbon-ion beam between ALA and PpIX, but ALA displayed a slightly higher radiosensitizing activity than PpIX.

Production of mitochondrial ROS in reaction to combination of carbon-ion beam with ALA or PpIX. The radiosensitizing effect of ALA and PpIX to carbon-ion beam may be related to the production of ROS in mitochondria, as previously shown in the case of X-rays (14-16). Therefore, mitochondrial ROS production was measured when carbon-ion beam was combined with ALA or PpIX. At 1 Gy radiation, the combined use of carbon-ion beam and ALA was about 1.46 times that of control, and the combined use of carbon-ion beam and PpIX was about 1.26 times (Figure 2), indicating significant increase in ROS production in mitochondria. Similar to results shown in Figure 1, addition of ALA showed higher mitochondrial ROS production than the addition of PpIX.

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Radiosensitizing activity of ALA and PpIX on carbon-ion beam. C: Control; A: ALA; P: PpIX. Each experiment was performed three times; data are the mean±SD (*p<0.05).

DNA double-strand breaks by combination of carbon-ion beam and ALA or PpIX. DNA double-strand breakage is pivotal in cancer cell death by radiation. DNA double strand breakage activity was measured 3 h after irradiation with 1 Gy carbon-ion beam. Combined use of ALA with carbon-ion beam showed a significant increase of 1.16 times in γ-H2AX focus number when compared to the control (Figure 3). On the contrary, combination of carbon-ion beam with PpIX showed no significant increase in γ-H2AX focus number compared to the control (Figure 3).

Localization of intracellular PpIX. In order to clarify whether the intracellular localization of PpIX is related to its effects on the radiosensitization of carbon-ion beam, ROS productivity in mitochondria, and DNA double strand breakage activity, intracellular PpIX localization at the time of carbon irradiation was evaluated. PpIX synthesized from ALA was mainly localized in mitochondria and cytoplasm and confined slightly in the nucleus (Figure 4). On the contrary, when PpIX was added, it was mainly localized in the nucleus, and almost no localization of PpIX in mitochondria and cytoplasm was observed (Figure 4).

Figure 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2.

Production of mitochondrial ROS by combination of carbon beam with ALA or PpIX. Each experiment was performed three times; data are the mean±SD (*p<0.05).

Figure 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 3.

DNA double-strand breaks by combination of carbon beam with ALA or PpIX. Each experiment was performed three times; data are the mean±SD (*p<0.05).

Figure 4.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 4.

Localization of intracellular PpIX. Mitotracker: Mitochondria; Hoechst33342: nucleus.

Discussion

In this study, the radiosensitizing activity of ALA and PpIX on carbon-ion beam and its mode of action were analyzed. Since ALA is converted into PpIX in mitochondria and PpIX, which is a porphyrin compound, has antitumor activity in combination with visible light (photodynamic therapy) and ultrasound (sonodynamic therapy) (12), PpIX was predicted to be the active component. However, since ALA displayed a higher carbon-ion beam sensitizing effect than PpIX, we concluded that the localization of PpIX to mitochondria, where PpIX is biosynthesized from ALA, is crucial. Indeed, the examination of the intracellular localization of PpIX supported our hypothesis: PpIX derived from ALA was mainly localized in the mitochondria, but extraneous PpIX was predominantly present in the nucleus.

In recent years, it has been thought that not only nuclear DNA damage due to irradiation induced by ROS, but also delayed ROS production centered on mitochondria, plays an important role as a biological response to tumor irradiation. It has also been reported that ALA increases delayed ROS production occurring after irradiation, centered on mitochondria (19, 20). Our results support the conclusion that there is delayed ROS production in the mitochondria after ALA treatment.

In conclusion, ALA is converted to PpIX in the mitochondria and interacts with carbon-ion beam to produce ROS and exert its cytotoxic activity.

  • Received April 11, 2018.
  • Revision received May 14, 2018.
  • Accepted May 15, 2018.
  • Copyright© 2018, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved

References

  1. ↵
    1. Mohamad O,
    2. Makishima H,
    3. Kamada T
    : Evolution of carbon ion radiotherapy at the National Institute of Radiological Sciences in Japan. Cancers (Basel) 10: 66, 2018.
    OpenUrl
    1. Fukumura A,
    2. Tsujii H,
    3. Kamada T,
    4. Baba M,
    5. Tsuji H,
    6. Kato H,
    7. Kato S,
    8. Yamada S,
    9. Yasuda S,
    10. Yanagi T,
    11. Kato H,
    12. Hara R,
    13. Yamamoto N,
    14. Mizoe J,
    15. Akahane K,
    16. Fukuda S,
    17. Furusawa Y,
    18. Iwata Y,
    19. Kanai T,
    20. Kanematsu N,
    21. Kitagawa A,
    22. Matsufuji N,
    23. Minohara S,
    24. Miyahara N,
    25. Mizuno H,
    26. Murakami T,
    27. Nishizawa K,
    28. Noda K,
    29. Takada E,
    30. Yonai S
    : Carbon-ion radiotherapy: clinical aspects and related dosimetry. Radiat Prot Dosimetry 137: 149-155, 2009.
    OpenUrlCrossRefPubMed
  2. ↵
    1. Abe M
    : Charged particle radiotherapy at the Hyogo Ion Beam Medical Center: Characteristics, technology and clinical results. Proc Jpn Acad Ser B Phys Biol Sci 83: 151-163, 2007.
    OpenUrl
  3. ↵
    1. Oike T,
    2. Niimi A,
    3. Okonogi N,
    4. Murata K,
    5. Matsumura A,
    6. Noda SE,
    7. Kobayashi D,
    8. Iwanaga M,
    9. Tsuchida K,
    10. Kanai T,
    11. Ohno T,
    12. Shibata A,
    13. Nakano T
    : Visualization of complex DNA double-strand breaks in a tumor treated with carbon ion radiotherapy. Sci Rep 6: 22275, 2016.
    OpenUrl
  4. ↵
    1. Wada S,
    2. Van Khoa T,
    3. Kobayashi Y,
    4. Funayama T,
    5. Ogihara K,
    6. Ueno S,
    7. Ito N
    : Prediction of cellular radiosensitivity from DNA damage induced by gamma-rays and carbon ion irradiation in canine tumor cells. J Vet Med Sci 67: 1089-1095, 2005.
    OpenUrlCrossRefPubMed
  5. ↵
    1. Tsujii H,
    2. Kamada T
    : A review of update: clinical results of carbon ion radiotherapy. Jpn J Clin Oncol 42: 670-685, 2012.
    OpenUrlCrossRefPubMed
  6. ↵
    1. Saito K,
    2. Funayama T,
    3. Yokota Y,
    4. Murakami T,
    5. Kobayashi Y
    : Histone deacetylase inhibitors sensitize murine B16F10 melanoma cells to carbon ion irradiation by inducing G1 phase arrest. Biol Pharm Bull 40: 844-851, 2017.
    OpenUrl
    1. Lee Y,
    2. Sunada S,
    3. Hirakawa H,
    4. Fujimori A,
    5. Nickoloff JA,
    6. Okayasu R
    : TAS-116, a novel Hsp90 inhibitor, selectively enhances radiosensitivity of human cancer cells to X-rays and carbon ion radiation. Mol Cancer Ther 16: 16-24, 2017.
    OpenUrlAbstract/FREE Full Text
  7. ↵
    1. Baek SJ,
    2. Sato K,
    3. Nishida N,
    4. Koseki J,
    5. Azuma R,
    6. Kawamoto K,
    7. Konno M,
    8. Hayashi K,
    9. Satoh T,
    10. Doki Y,
    11. Mori M,
    12. Ishii H,
    13. Ogawa K
    : MicroRNA miR-374, a potential radiosensitizer for carbon ion beam radiotherapy. Oncol Rep 36: 2946-2950, 2016.
    OpenUrl
  8. ↵
    1. Nishimura M,
    2. Murayama Y,
    3. Harada K,
    4. Kamada Y,
    5. Morimura R,
    6. Ikoma H,
    7. Ichikawa D,
    8. Fujiwara H,
    9. Okamoto K,
    10. Otsuji E
    : Photodynamic diagnosis of hepatocellular carcinoma using 5-aminolevulinic acid. Anticancer Res 36: 4569-4574, 2016.
    OpenUrlAbstract/FREE Full Text
    1. Bodner K,
    2. Bodner-Adler B,
    3. Wierrani F,
    4. Kubin A,
    5. Szölts-Szölts J,
    6. Spängler B,
    7. Grünberger W
    : Cold-knife conization versus photodynamic therapy with topical 5-aminolevulinic acid (5-ALA) in cervical intraepithelial neoplasia (CIN) II with associated human papillomavirus infection: a comparison of preliminary results. Anticancer Res 23: 1785-1788, 2003.
    OpenUrlPubMed
  9. ↵
    1. Ishizuka M,
    2. Abe F,
    3. Sano Y,
    4. Takahashi K,
    5. Inoue K,
    6. Nakajima M,
    7. Kohda T,
    8. Komatsu N,
    9. Ogura S,
    10. Tanaka T
    : Novel development of 5-aminolevurinic acid (ALA) in cancer diagnoses and therapy. Int Immunopharmacol 11: 358-365, 2011.
    OpenUrlCrossRefPubMed
  10. ↵
    1. Gibson SL,
    2. Nguyen ML,
    3. Havens JJ,
    4. Barbarin A,
    5. Hilf R
    : Relationship of delta-aminolevulinic acid-induced protoporphyrin IX levels to mitochondrial content in neoplastic cells in vitro. Biochem Biophys Res Commun 265: 315-321, 1999.
    OpenUrlCrossRefPubMed
  11. ↵
    1. Takahashi J1,
    2. Misawa M,
    3. Murakami M,
    4. Mori T,
    5. Nomura K,
    6. Iwahashi H
    : 5-Aminolevulinic acid enhances cancer radiotherapy in a mouse tumor model. Springerplus 12: 602, 2013.
    OpenUrl
    1. Yamamoto J,
    2. Ogura S,
    3. Tanaka T,
    4. Kitagawa T,
    5. Nakano Y,
    6. Saito T,
    7. Takahashi M,
    8. Akiba D,
    9. Nishizawa S
    : Radiosensitizing effect of 5-aminolevulinic acid-induced protoporphyrin IX in glioma cells in vitro. Oncol Rep 27: 1748-1752, 2012.
    OpenUrlPubMed
  12. ↵
    1. Yamamoto J,
    2. Ogura S,
    3. Shimajiri S,
    4. Nakano Y,
    5. Akiba D,
    6. Kitagawa T,
    7. Ueta K,
    8. Tanaka T,
    9. Nishizawa S
    : 5-aminolevulinic acid-induced protoporphyrin IX with multi-dose ionizing irradiation enhances host antitumor response and strongly inhibits tumor growth in experimental glioma in vivo. Mol Med Rep 11: 1813-1819, 2015.
    OpenUrl
  13. ↵
    1. Uto Y,
    2. Tamatani D,
    3. Mizuki Y,
    4. Endo Y,
    5. Nakanishi I,
    6. Ohkubo K,
    7. Fukuzumi S,
    8. Ishizuka M,
    9. Tanaka T,
    10. Kuchiike D,
    11. Kubo K,
    12. Inui T,
    13. Hori H
    : Evaluation of the sonosensitizing activities of 5-aminolevulinic acid and Sn(IV) chlorine 6 in tumor-bearing chick embryos. Anticancer Res 34: 4583-4587, 2014.
    OpenUrlAbstract/FREE Full Text
  14. ↵
    1. Shimamura Y,
    2. Tamatani D,
    3. Kuniyasu S,
    4. Mizuki Y,
    5. Suzuki T,
    6. Katsura H,
    7. Yamada H,
    8. Endo Y,
    9. Osaki T,
    10. Ishizuka M,
    11. Tanaka T,
    12. Yamanaka N,
    13. Kurahashi T,
    14. Uto Y
    : 5-Aminolevulinic acid enhances ultrasound-mediated antitumor activity via mitochondrial oxidative damage in breast cancer. Anticancer Res 36: 3607-3612, 2016.
    OpenUrlAbstract/FREE Full Text
  15. ↵
    1. Kitagawa T,
    2. Yamamoto J,
    3. Tanaka T,
    4. Nakano Y,
    5. Akiba D,
    6. Ueta K,
    7. Nishizawa S
    : 5-Aminolevulinic acid strongly enhances delayed intracellular production of reactive oxygen species (ROS) generated by ionizing irradiation: quantitative analyses and visualization of intracellular ROS production in glioma cells in vitro. Oncol Rep 33: 583-590, 2015.
    OpenUrl
  16. ↵
    1. Ueta K,
    2. Yamamoto J,
    3. Tanaka T,
    4. Nakano Y,
    5. Kitagawa T,
    6. Nishizawa S
    : 5-Aminolevulinic acid enhances mitochondrial stress upon ionizing irradiation exposure and increases delayed production of reactive oxygen species and cell death in glioma cells. Int J Mol Med 39: 387-398, 2017.
    OpenUrl
PreviousNext
Back to top

In this issue

Anticancer Research: 38 (7)
Anticancer Research
Vol. 38, Issue 7
July 2018
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Radiosensitizing Effect of 5-Aminolevulinic Acid and Protoporphyrin IX on Carbon-ion Beam Irradiation
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
12 + 0 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Radiosensitizing Effect of 5-Aminolevulinic Acid and Protoporphyrin IX on Carbon-ion Beam Irradiation
TOMOKO KANEKO, MASAHIDE TOMINAGA, RISA KOUZAKI, AYAKA HANYU, KAZUKI UESHIMA, HISATSUGU YAMADA, MASAKI SUGA, TOMOHIRO YAMASHITA, TOMOAKI OKIMOTO, YOSHIHIRO UTO
Anticancer Research Jul 2018, 38 (7) 4313-4317; DOI: 10.21873/anticanres.12730

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Radiosensitizing Effect of 5-Aminolevulinic Acid and Protoporphyrin IX on Carbon-ion Beam Irradiation
TOMOKO KANEKO, MASAHIDE TOMINAGA, RISA KOUZAKI, AYAKA HANYU, KAZUKI UESHIMA, HISATSUGU YAMADA, MASAKI SUGA, TOMOHIRO YAMASHITA, TOMOAKI OKIMOTO, YOSHIHIRO UTO
Anticancer Research Jul 2018, 38 (7) 4313-4317; DOI: 10.21873/anticanres.12730
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

PROCEEDINGS OF THE 21st ANNUAL MEETING OF THE SOCIETY OF BIOTHERAPEUTIC APPROACHES

  • Phagocytic Activation of Macrophages with Serum MAF Depends on Engulfment Efficiency and Not Migratory Activity
  • Seizures and Tumor Progression in Glioma Patients with Uncontrollable Epilepsy Treated with Perampanel
  • Construction of Anti-HER2 Recombinants as Targeting Modules for a Drug-delivery System Against HER2-positive Cells
Show more PROCEEDINGS OF THE 21st ANNUAL MEETING OF THE SOCIETY OF BIOTHERAPEUTIC APPROACHES

Experimental Studies

  • Phagocytic Activation of Macrophages with Serum MAF Depends on Engulfment Efficiency and Not Migratory Activity
  • Seizures and Tumor Progression in Glioma Patients with Uncontrollable Epilepsy Treated with Perampanel
  • Construction of Anti-HER2 Recombinants as Targeting Modules for a Drug-delivery System Against HER2-positive Cells
Show more Experimental Studies

Similar Articles

Keywords

  • 5-aminolevulinic acid
  • protoporphyrin IX
  • carbon-ion beam
  • reactive oxygen species
  • mitochondria
Anticancer Research

© 2023 Anticancer Research

Powered by HighWire